Clinical Trials in Illinois

Showing 17461-17480 of 19,692 trials

PS-341 in Treating Patients With Metastatic Kidney Cancer

NCT00025376

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which regimen of PS-341 is more effective in treating metastatic kidney cancer. PURPOSE: Randomized phase III trial to study the effectiveness of PS-341 in treating patients who have metastatic kidney cancer.

Kidney Cancer

University of Chicago23 participantsStarted Oct 2001

Chicago, Illinois, United States • Chicago, Illinois, United States • Decatur, Illinois, United States +7 more locations

COMPLETEDPhase 1/235 miles

Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

NCT00026299

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Biological therapies such as gefitinib may interfere with the growth of the tumor cells and slow the growth of colorectal cancer. Combining chemotherapy with gefitinib may kill more tumor cells. PURPOSE: Phase I/II trial to compare the effectiveness of chemotherapy with or without gefitinib in treating patients who have metastatic or locally recurrent colorectal cancer.

Colorectal Cancer

University of Chicago14 participantsStarted Sep 2001

Chicago, Illinois, United States • Chicago, Illinois, United States • Decatur, Illinois, United States +9 more locations

PS-341 in Treating Patients With Metastatic Kidney Cancer

Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Find Trials by Condition in Illinois

Aminocamptothecin in Treating Patients With Stomach Cancer or Cancer of the Esophagus

Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma

OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.

RNS® System Pivotal Study

Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44

A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).

VX-710, Doxorubicin, and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung Cancer

Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

A Study of Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials

The Evaluation of Infant Formulas Fed to Infants With Common Feeding Problems

Topical Antifungal Treatment for Tinea Cruris

Impact of a Diabetes Risk Score on Lifestyle Education and Patient Adherence

CPT for Offenders With SUD

Study on OsseoSpeed™ Implants in Patients Missing 2-5 Teeth in the Posterior Lower Jaw, Restored With Permanent Teeth Attached 6-7 Weeks Later

Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.

Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)

Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss

Intervention to Retain HIV-positive Patients in Medical Care